Heather Barrington

Heather Barrington

Auto-generated profile, based on publicly available information

Heather Barrington

Health Data Science Department, University of Liverpool, Liverpool, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
HBHeather Barrington
Heather Barrington
BYBridget Young
Bridget Young
PWPaula R Williamson
Paula R Williamson
Objectives To describe the design and conduct of core outcome set (COS) studies that have included patients as participants, exploring how study characteristics might impact their response rates. Design Systematic review of COS studies published between 2015 and 2019 that included more than one patient, carer or representative as participants (hereafter referred to as patients for brevity) in scoring outcomes in a Delphi. Results There were variations in the design and conduct of COS studies that included patients in the Delphi process, including differing: scoring and feedback systems, approaches to recruiting patients, length of time between rounds, use of reminders, incentives, patient and public involvement, and piloting. Minimal reporting of participant characteristics and a lack of translation of Delphi surveys into local languages were found. Additionally, there were indications that studies that recruited patients through treatment centres had higher round two response rates than studies recruiting through patient organisations. Conclusions Variability was striking in how COS Delphi surveys were designed and conducted to include patient participants and other stakeholders. Future research is needed to explore what motivates patients to take part in COS studies and what factors influence COS developer recruitment strategies. Improved reporting would increase knowledge of how methods affect patient participation in COS Delphi studies.

9 May 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
CMChristopher P. Millward
Christopher P. Millward
TATerri S Armstrong
Terri S Armstrong
HBHeather Barrington
Heather Barrington
SBSabrina Bell
Sabrina Bell
ABAndrew R Brodbelt
Andrew R Brodbelt
MJMichael D Jenkinson
Michael D Jenkinson
Introduction Meningioma is the most common primary intracranial tumour in adults. The majority are non-malignant, but a proportion behave more aggressively. Incidental/minimally symptomatic meningioma are often managed by serial imaging. Symptomatic meningioma, those that threaten neurovascular structures, or demonstrate radiological growth, are usually resected as first-line management strategy. For patients in poor clinical condition, or with inoperable, residual or recurrent disease, radiotherapy is often used as primary or adjuvant treatment. Effective pharmacotherapy treatments do not currently exist. There is heterogeneity in the outcomes measured and reported in meningioma clinical studies. Two ‘Core Outcome Sets’ (COS) will be developed: (COSMIC: Intervention) for use in meningioma clinical effectiveness trials and (COSMIC: Observation) for use in clinical studies of incidental/untreated meningioma. Methods and analysis Two systematic literature reviews and trial registry searches will identify outcomes measured and reported in published and ongoing (1) meningioma clinical effectiveness trials, and (2) clinical studies of incidental/untreated meningioma. Outcomes include those that are clinician reported, patient reported, caregiver reported and based on objective tests (eg, neurocognitive tests), as well as measures of progression and survival. Outcomes will be deduplicated and categorised to generate two long lists. The two long lists will be prioritised through two, two-round, international, modified eDelphi surveys including patients with meningioma, healthcare professionals, researchers and those in caring/supporting roles. The two final COS will be ratified through two 1-day online consensus meetings, with representation from all stakeholder groups. Ethics and dissemination Institutional review board (University of Liverpool) approval was obtained for the conduct of this study. Participant eConsent will be obtained prior to participation in the eDelphi surveys and consensus meetings. The two systematic literature reviews and two final COS will be published and freely available. Trial registration number COMET study ID 1508

18 August 2026 in BMJ Open
Verified
Journal Article
Open access
HBHeather Barrington
Heather Barrington
RCRebecca Craven
Rebecca Craven
PWPaula R Williamson
Paula R Williamson
BYBridget Young
Bridget Young
Background: The use of core outcome sets (COSs) in health research is widely recommended. COSs are developed with input from key decision makers, patients being a vital group to ensure COS relevance. However, recruitment to COS studies can be challenging. Objectives: The study aimed to explore what patients and the public think of COS study invitations, which are usually the first document a patient reads about a COS study. Design: Qualitative study involving focus groups and interviews. Analysis of transcribed data drew on reflexive thematic analysis. Participants and setting: Focus groups and interviews were conducted with a diverse range of patients and the public (n=31) from community and patient groups in North West England, exploring their perceptions of a sample of COS study invitations. Participants were eligible if aged over 18 years, they could speak English and had never previously participated in a COS study. Results: Themes identified included understanding, engagement, safety and accessibility. Participants were concerned about excessive information in the invitations which made them confused. Fear of cybercrime caused numerous concerns and participants were reluctant to click on links or attachments. Trust in the people sending the invitations was key. Participants wanted to see messages that COS studies had a meaningful purpose to feel their contributions were valuable. They were keen to contribute to improving future ‘treatment’ but less motivated to improve ‘research’. Messages that evoked a feeling of connection with others who they could relate to were positively regarded. Participants also highlighted ways that invitations could be made more accessible. Conclusion: COS invitations can present numerous challenges for potential participants, but our study indicates ways that COS developers can address these challenges and make their invitations more appealing to potential participants. As part of the wider Good Research Invitation Study the findings have been used to inform guidance on designing a good COS invitation

18 August 2026 in BMJ Open
Verified
Journal Article
Open access
PDF file
HBHeather Barrington
Heather Barrington
RCRebecca Craven
Rebecca Craven
PWPaula R Williamson
Paula R Williamson
BYBridget Young
Bridget Young
Background: It is crucial that the outcomes used in clinical effectiveness studies are relevant to patients. This relevance can be assured by patients participating with other key stakeholders in core outcome set (COS) studies, yet recruiting patients to such studies can be challenging. Objectives: As no guidance currently exists to help COS developers create good COS invitations for patients, which are usually the first documents patients see when invited to participate in COS studies, the Good Research Invitation Study aimed to produce such guidance. Design: Consensus meeting to agree on guidance for COS developers designing research invitations. Setting and participants: Informed by findings from our previous qualitative study of patient and public opinions on COS study invitations, our team, which included a patient research partner, produced an initial set of candidate recommendations. An online consensus meeting was organised in the UK with 13 participants including patient research partners with and without COS study experience, COS developers, a representative from an ethics committee and experts in diversity, marketing and science communication. Through a process of discussion and voting, the initial set of recommendations was refined. Results: From the initial 35 recommendations, consensus meeting participants agreed a final set of 22 recommendations. Some initial recommendations were removed as they were beyond the scope, while others were merged. The finalised recommendations focused on producing and user testing invitations, reaching the audience, engaging potential COS participants and considering what they might find appealing or off-putting, explaining and creating interest in the study, keeping the invitation simple and understandable, considering the amount of information to include and how to present it, alongside ensuring accessibility. Discussion during the meeting highlighted the importance of improving the accessibility of all participant-facing resources in COS studies, not just the invitations. Conclusion: Through consensus, a set of recommendations has been agreed on for use by COS developers to enhance study invitations for patients. Further testing and refinement of the recommendations will improve their utility.